from 10-K 30 pages AN2 Therapeutics, Inc. 2022 Equity Incentive Plan Adopted by the Board of Directors: March 17, 2022 Approved by the Stockholders: March 18, 2022

from 10-K 6 pages AN2 Therapeutics, Inc. Rsu Award Grant Notice

from 10-K 14 pages The Plan Includes Two Components: A 423 Component and a Non-423 Component. the Company Intends (But Makes No Undertaking or Representation to Maintain) the 423 Component to Qualify as an Employee Stock Purchase Plan. the Provisions of the 423 Component, Accordingly, Will Be Construed in a Manner That Is Consistent With the Requirements of Section 423 of the Code. Except as Otherwise Provided in the Plan or Determined by the Board, the Non-423 Component Will Operate and Be Administered in the Same Manner as the 423 Component. (C) the Company, by Means of the Plan, Seeks to Retain the Services of Such Employees, to Secure and Retain the Services of New Employees, and to Provide Incentives for Such Persons to Exert Maximum Efforts for the Success of the Company and Its Related Corporations. 2. Administration. (A) the Board or the Committee Will Administer the Plan. References Herein to the Board Shall Be Deemed to Refer to the Committee Except Where Context Dictates Otherwise. (B) the Board Will Have the Power, Subject To, and Within the Limitations Of, the Express Provisions of the Plan: (I) to Determine How and When Purchase Rights Will Be Granted and the Provisions of Each Offering (Which Need Not Be Identical)

from 10-K 2 pages Consent of expert or counsel

from 10-K 2 pages Management certification of annual or quarterly disclosure

from 10-K 2 pages Management certification of annual or quarterly disclosure

from 10-K 2 pages Management certification of financial report

from 10-K 2 pages Management certification of financial report

from 10-K 7 pages  

from 10-K img91092122_0.jpg